Alzheimer’s: Canada’s Drug Agency recommends funding this drug to slow early stages CTV NewsCanada’s Drug Agency reverses course, now recommends public drug plans cover Alzheimer’s drug The Globe and MailCanada’s Drug Agency recommends funding lecanemab for early-stage Alzheimer’s disease CityNews Toronto
